Mega Contracts Monitor ($100M+) — July 01, 2026

Harris Corporation secured a $1.24 billion contract from the Department of Transportation, representing 75% of total digest value. The award is bullish due to its sheer size and sole-source nature, implying a competitive moat or urgent need, though limited data on pricing and competition reduces confidence.

Leidos secured a $113.5 million cost-plus-fixed-fee delivery order from NIH for agile software development, with options that could double the value to $247.1 million. The cost-plus structure reduces profit risk, and NIH’s stable budget supports contract durability.

Amentum Services’ $204M cost-plus-fixed-fee contract with NASA ends in August 2023, with no options beyond that date. The contract generated $34M annual revenue for Jacobs, and its expiration creates a near-term revenue gap unless recompeted.

Management & Training Corporation’s $115.5M firm-fixed-price contract to operate the Atterbury Job Corps Center ends November 2024 with no extension options. The firm-fixed-price structure carries medium cost risk, and the recompete outcome is uncertain.

The Harris Corporation $1.24B DOT award constitutes 75% of total digest value, creating extreme single-contract concentration. Any disruption (protest, budget cut, performance failure) would disproportionately impact the aggregate signal.

Management & Training Corporation’s $115.5M firm-fixed-price contract carries medium cost risk; if operational costs exceed projections, margins could compress. The contract is labor-intensive (Job Corps training), making it sensitive to wage inflation.

Amentum Services’ NASA contract ends August 2023 with no options, creating a $34M annual revenue gap for Jacobs Engineering. NASA’s testing lab budget is stable, but recompete timing and competition are unknown.

Leidos’ $113.5M NIH delivery order for agile software development supports the federal digital modernization theme. If options are exercised, total value could reach $247.1M, signaling sustained NIH investment in the eRA grants management system.

Though no defense contracts appear in this digest, Harris Corporation’s $1.24B DOT award demonstrates its ability to win large civilian contracts, potentially diversifying its revenue base beyond defense. Investors should monitor for follow-on DOT awards.

All four contracts in this digest are from civilian agencies (DOT, NASA, HHS/NIH, DOL), totaling $1.66 billion with zero defense exposure. This contrasts with typical defense-heavy mega-contract monitors and suggests a temporary shift in federal procurement priorities toward infrastructure, space, health IT, and workforce training.

Two of four contracts (Amentum/NASA and Leidos/NIH) use cost-plus-fixed-fee pricing, which reduces profit risk for contractors. This structure is common in civilian R&D and IT services, providing stable margins even amid budget uncertainty.

{"entity"=>"Jacobs Engineering Group (via Amentum Services)", "reason"=>"Amentum’s $204M NASA contract ends August 2023, representing $34M annual revenue. Recompete outcome is critical.", "trigger"=>"NASA recompete solicitation for Kennedy Space Center lab support expected before August 2023"}

{"entity"=>"Leidos, Inc.", "reason"=>"Leidos’ $113.5M NIH delivery order has options that could double value to $247.1M. Option exercise signals continued NIH investment.", "trigger"=>"NIH option exercise decision within 3-year base period (by June 2027)"}

{"entity"=>"Management & Training Corporation", "reason"=>"DOL Job Corps contract ends November 2024; recompete outcome will determine revenue continuity.", "trigger"=>"DOL recompete solicitation for Atterbury Job Corps Center expected before November 2024"}

{"entity"=>"Harris Corporation", "reason"=>"$1.24B DOT contract is 75% of digest value but lacks pricing/competition details. Any protest or budget cut would be material.", "trigger"=>"DOT FY2027 budget request or any protest filing against sole-source award"}